Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 1

1(33.3%)

3Total

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04824976Not ApplicableUnknown

Effects of Blueberries on Symptoms and Underlying Mechanisms of Functional Gastrointestinal Disorders

Role: lead

NCT02087345Unknown

Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion

Role: lead

NCT02085889Unknown

Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders

Role: lead

NCT04331223Completed

The Association of Clinical Symptom Clusters With Underlying Mechanisms in Functional Gastrointestinal Disorders

Role: lead

NCT01705171Completed

Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?

Role: lead

NCT02614313Not ApplicableCompleted

Fructose Breath-testing in Irritable Bowel Syndrome (IBS)

Role: lead

NCT00564330Phase 1Completed

In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole

Role: lead

All 7 trials loaded